BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medinol Celebrates First-in-Human Implantation of ChampioNIR Drug-Eluting Peripheral Stent in Australia

Medinol Ltd. is pleased to announce the successful First-in-Human (FIH) implantation of the ChampioNIR Drug-Eluting Peripheral Stent by Drs Gerard S.G...

October 07, 2024 | News

Telix Pharmaceuticals Doses First Patient in Phase II Trial for Advanced Kidney Cancer Imaging Agent

Telix Pharmaceuticals Limited announces that the first patient has been dosed in a Phase II trial exploring the clinical utility of Telix's first-in-class ...

October 04, 2024 | News

Global Rett Syndrome Breakthroughs Highlighted by Australian Researcher at World Congress

Australian researcher Associate Professor Wendy Gold, a world leader in Rett Syndrome research from the University of Sydney, joins int...

October 02, 2024 | News

BioCina Partners with EnGeneIC to Accelerate Manufacturing of Cutting-Edge Cancer Treatment

BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization (CDMO), announced a new partnership with drug deve...

September 25, 2024 | News

Telix Pharmaceuticals to Acquire RLS Radiopharmacies, Expanding U.S. Manufacturing Footprint and Radiometal Production Network

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and RLS (USA) Inc. (RLS Radiopharmacies), the only Joint Commission-accredited radiopharmacy n...

September 23, 2024 | News

See-Mode Technologies Receives FDA Clearance for AI-Powered Thyroid Ultrasound Analysis Software

See-Mode Technologies, a global innovator in AI for ultrasound imaging, announced the receipt of 510(k) clearance from the U.S. Food and Drug Administ...

September 18, 2024 | News

Genea Biomedx Joins Basecare Medical to Drive Global Expansion of Assisted Reproductive Technology

Genea Biomedx, which was once part of Genea Fertility, joined the Basecare Medical group in 2023 with the aim of distributing Basecare's assisted reproduct...

September 13, 2024 | News

Australia Faces Urgent Call to Address Childhood Dementia Crisis in New 2024 Report

A groundbreaking new report, "State of Childhood Dementia in Australia 2024," released at Australia's Parliament House in Ca...

September 10, 2024 | Report

Innovent Biologics Receives FDA Fast Track Designation for PD-1/IL-2α Bispecific Antibody in Advanced Melanoma Treatment

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...

September 04, 2024 | News

Telix Pharmaceuticals Submits NDA to FDA for Innovative Brain Cancer Imaging Agent Pixclara®

Telix Pharmaceuticals announces it has submitted a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA) for ...

August 28, 2024 | News

GE HealthCare and Roche Diagnostics Partner to Transform Precision Cancer Care in Asia Pacific

GE HealthCare and Roche Diagnostics have entered into a Memorandum of Understanding (MOU) that will leverage the strengths and resources of both comp...

August 22, 2024 | News

STADA Expands APAC Consumer Healthcare Portfolio with Acquisition of Nizoral Cream from Janssen

well as the trademark rights (TM) in Hong Kong, Australia, Indonesia, Malaysia, New Zealand and Singapore This transaction continues the successful acqu...

August 21, 2024 | News

STADA Expands APAC Consumer Healthcare Portfolio with Acquisition of Nizoral Cream from Janssen

well as the trademark rights (TM) in Hong Kong, Australia, Indonesia, Malaysia, New Zealand and Singapore This transaction continues the successful acqu...

August 20, 2024 | News

Noxopharm Targets First-in-Human Clinical Trial for First-in-Class Drug SOF-SKN™

Highlights: First-in-human clinical trial for SOF-SKN™ and Sofra™ platform Efficient trial design with early results expected Le...

August 19, 2024 | News

Stay Connected